Pharmacokinetic analysis demonstrates palbociclib and ribociclib interactions with proton pump inhibitors in drug regimens, highlighting co-administration risks.
The study investigated pharmacokinetic interactions between palbociclib and ribociclib with proton pump inhibitors (PPIs) using the reverse-phase high-performance liquid chromatography (RP-HPLC) method.
No takes yet. Share an insight, caveat, or question.
Desai et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: